These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 7807300)

  • 1. Bovine surfactant therapy and retinopathy of prematurity.
    McGinnity FG; Girschek PK; Morin JD; O'Donoghue EP; Dunn MS
    J Pediatr Ophthalmol Strabismus; 1994; 31(4):238-41. PubMed ID: 7807300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calf lung surfactant extract prophylaxis and retinopathy of prematurity.
    Repka MX; Hudak ML; Parsa CF; Tielsch JM
    Ophthalmology; 1992 Apr; 99(4):531-6. PubMed ID: 1584570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retinopathy of prematurity in surfactant treated infants.
    Rankin SJ; Tubman TR; Halliday HL; Johnston SS
    Br J Ophthalmol; 1992 Apr; 76(4):202-4. PubMed ID: 1390486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surfactant replacement therapy and the prevalence of acute retinopathy of prematurity.
    Tubman TR; Rankin SJ; Halliday HL; Johnston SS
    Biol Neonate; 1992; 61 Suppl 1():54-8. PubMed ID: 1391267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized clinical trial of surfactant prophylaxis in retinopathy of prematurity.
    Holmes JM; Cronin CM; Squires P; Myers TF
    J Pediatr Ophthalmol Strabismus; 1994; 31(3):189-91. PubMed ID: 7931953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retinopathy of prematurity and surfactant treatment.
    Axer-Siegel R; Snir M; Ma'ayan A; Na'or N; Davidson S; Weinberger D; Yassur Y
    J Pediatr Ophthalmol Strabismus; 1996; 33(3):171-4. PubMed ID: 8771520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of oxygen on the development and severity of retinopathy of prematurity.
    Hartnett ME; Lane RH
    J AAPOS; 2013 Jun; 17(3):229-34. PubMed ID: 23791404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Animal derived surfactant extract for treatment of respiratory distress syndrome.
    Seger N; Soll R
    Cochrane Database Syst Rev; 2009 Apr; (2):CD007836. PubMed ID: 19370695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surfactant replacement therapy: a new risk factor in developing retinopathy of prematurity?
    Termote JU; Schalij-Delfos NE; Wittebol-Post D; Brouwers HA; Hoogervorst BR; Cats BP
    Eur J Pediatr; 1994 Feb; 153(2):113-6. PubMed ID: 8157017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early regular versus late selective poractant treatment in preterm infants born between 25 and 30 gestational weeks: a prospective randomized multicenter study.
    Dilmen U; Özdemir R; Tatar Aksoy H; Uras N; Demirel N; Kırimi E; Erdeve Ö; Özer E; Baş AY; Gürsoy T; Zenciroğlu A; Ovalı F; Oğuz ŞS
    J Matern Fetal Neonatal Med; 2014 Mar; 27(4):411-5. PubMed ID: 23795582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Are there predictors for proliferative retinopathy of prematurity and is supplemental oxygen a useful conservative treatment option?].
    Müller H; Weiss C; Kuntz S; Akkoyun I; Schaible T
    Klin Padiatr; 2005; 217(2):53-60. PubMed ID: 15770574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neonatal respiratory distress syndrome and surfactant therapy; a brief review.
    Robertson B
    Eur Respir J Suppl; 1989 Mar; 3():73s-76s. PubMed ID: 2662999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postnatal risk factors of retinopathy of prematurity.
    Kim TI; Sohn J; Pi SY; Yoon YH
    Paediatr Perinat Epidemiol; 2004 Mar; 18(2):130-4. PubMed ID: 14996252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surfactant replacement therapy with a single postventilatory dose of a reconstituted bovine surfactant in preterm neonates with respiratory distress syndrome: final analysis of a multicenter, double-blind, randomized trial and comparison with similar trials. The Surfactant-TA Study Group.
    Fujiwara T; Konishi M; Chida S; Okuyama K; Ogawa Y; Takeuchi Y; Nishida H; Kito H; Fujimura M; Nakamura H
    Pediatrics; 1990 Nov; 86(5):753-64. PubMed ID: 2235230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surfactant and ROP incidence.
    Rankin SJ; Tubman TR; Halliday HL; Johnston SS
    Ophthalmology; 1991 Aug; 98(8):1148-9. PubMed ID: 1923348
    [No Abstract]   [Full Text] [Related]  

  • 16. Surfactant prophylaxis and retinopathy of prematurity.
    Repka MX; Hardy RJ; Phelps DL; Summers CG
    Arch Ophthalmol; 1993 May; 111(5):618-20. PubMed ID: 8489440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of surfactant-TA, calfactant and poractant alfa for preterm infants with respiratory distress syndrome: a retrospective study.
    Jeon GW; Oh M; Sin JB
    Yonsei Med J; 2015 Mar; 56(2):433-9. PubMed ID: 25683992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcome at twelve months of adjusted age in very low birth weight infants with lung immaturity: a randomized, placebo-controlled trial of human surfactant.
    Vaucher YE; Harker L; Merritt TA; Hallman M; Gist K; Bejar R; Heldt GP; Edwards D; Pohjavuori M
    J Pediatr; 1993 Jan; 122(1):126-32. PubMed ID: 8419599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Porcine versus bovine surfactant therapy for RDS in preterm neonates: pragmatic meta-analysis and review of physiopathological plausibility of the effects on extra-pulmonary outcomes.
    Foligno S; De Luca D
    Respir Res; 2020 Jan; 21(1):8. PubMed ID: 31910825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Respiratory support in preterm infants at birth.
    ;
    Pediatrics; 2014 Jan; 133(1):171-4. PubMed ID: 24379228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.